Resistance on the rise
Join Dr. Ahmed Babiker, Assistant Professor, Rush University, and Professor Elaine Cloutman-Green, Principal Clinical Scientist in Infection Control at Great Ormond Street Hospital for Children, London as they explore the evolution of superbugs and superbugs’ impact to clinical treatment. They will present case study examples, and discuss global infection prevention strategies to support antibiotic stewardship.
Key learning objectives
- Explore the evolution of superbugs and current top priority global threats
- Recognize the impact, and outcome, of resistant bacteria present in the clinical setting
- Explore key infection prevention strategies
Who should attend?
- Clinical microbiology lab directors/supervisors/managers
- Microbiologists
- Microbiologist lab technicians
- Infectious disease specialists
- Infectious disease pharmacists
- Clinical microbiology lab executives
- Antibiotic stewardship committee members
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
Dr. Ahmed Babiker is a dual trained infectious diseases and clinical microbiology physician scientist. His primary research interest is the clinical and molecular epidemiology of multi-drug-resistant healthcare-associated infections, the role of microbiome in colonization resistance, and antimicrobial resistance surveillance in low- and middle-income countries.
Professor Elaine Cloutman-Green is a principal clinical scientist in infection control at Great Ormond Street Hospital for Children in London (GOSH). She is also a clinical lecturer at the National Institute for Health Research (NIHR) and an Expert Advisor in Infection Prevention and Control at the National Institute for Health and Care Excellence (NICE).
Moderator
